Abstract
Medulloblastoma (MB) is the most common malignant brain tumor in children, where one-third of patients succumb to their disease. This SnapShot describes the classification of MB subgroups, historically by histopathology and currently based on genomic information. Genomics-based classification has identified four major subgroups and provides greater opportunity for developing targeted therapies more successful than current conventional therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 940-940.e1 |
Journal | Cancer cell |
Volume | 26 |
Issue number | 6 |
DOIs | |
State | Published - Dec 8 2014 |
ASJC Scopus subject areas
- Oncology
- Cell Biology
- Cancer Research